Long-term cognitive impairments and attentional deficits in patients with Cushing’s disease and cortisol-producing adrenal adenoma in remission
The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
CONTEXT: Cognitive function is impaired in patients with active Cushing's syndrome (CS). OBJECTIVE: The aim was to study cognitive function in patients with CS in long-term remission. DESIGN: We conducted a cross-sectional, case-controlled, single center study. PATIENTS: Fifty-five patients previously treated for Cushing's disease (n = 43) and cortisol-producing adrenal adenoma (n = 12) and 55 controls matched for age, gender, and educational level participated in the study. METHODS: Working memory, attention, information-processing speed, verbal fluency, and reading speed were studied using standardized neuropsychological testing and alerting, orienting, and executive control using the Attentional Network Test. Fatigue impact scale and the comprehensive psychopathological rating scale were used to evaluate fatigue and affective disorder. RESULTS: Median (interquartile range) duration of remission was 13 (5-19) yr and the mean ± SD age at follow-up was 54 ± 14 yr. Compared to controls, patients had a higher score on the fatigue impact scale, indicating greater burdens of fatigue, and a higher score on the comprehensive psychopathological rating scale subscales for depression and anxiety. In a multivariate analysis, attention, spatial orienting, alerting, working memory, verbal fluency, and reading speed were all diminished in comparison to controls, independent of scores for affective disorder and fatigue. No overall difference in outcome was seen between patients in long-term remission for Cushing's disease and cortisol-producing adrenal adenoma. CONCLUSION: Patients with CS in remission have impaired cognitive function that cannot be explained by the coexistence of affective disorder or chronic fatigue. The pattern of cognitive and attentional deficits suggests a more global involvement of the brain function than has previously been suggested.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Long-term effects of postnatal GC on the human brain include decreased memory and hippocampal volume (145), decreased cerebellar cortical volume (146), diminished cognitive function (147-149), increased psychopathology, and reduced QOL (148, 150)”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [147]
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
Neuropsychological assessment, 4th ed.
Lezak, M. D., Howieson, D. B., Loring, D. W., Hannay, H. J., & Fischer, J. S. (2004) · Cited by 4,413
The Neuropsychological Assessment
Ogden, J. A. (2005) · Fractured Minds · doi:10.1093/oso/9780195171358.003.0002 · Cited by 4,364
The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation
Reitan, R. M., & Wolfson, D. E. (1993) · Medical Entomology and Zoology · Cited by 3,870
DMDX: A Windows display program with millisecond accuracy
Forster, K. I., & Forster, J. C. (2003) · Behavior Research Methods, Instruments, & Computers · doi:10.3758/bf03195503 · Cited by 2,759
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
The activation of attentional networks
FAN, J., MCCANDLISS, B., FOSSELLA, J., FLOMBAUM, J., & POSNER, M. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.02.004 · Cited by 1,737
Measuring the Functional Impact of Fatigue: Initial Validation of the Fatigue Impact Scale
Fisk, J. D., Ritvo, P. G., Ross, L., Haase, D. A., Marrie, T. J., & Schlech, W. F. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.supplement_1.s79 · Cited by 1,541
Research works printed but not linked: 3
- Lezak, 2004, Neuropsychological assessment
- Delis, 2001, Executive function system-D-KEFS
- Järpsten, 2002, DLS handledning för skolår 7–9 och år 1 i gymnasiet
Cited by
Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
The Treatment of Cushing's Disease
Pivonello, R., De Leo, M., Cozzolino, A., & Colao, A. (2015) · Endocrine Reviews · doi:10.1210/er.2013-1048 · Cited by 465
Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance
Beaupere, C., Liboz, A., Fève, B., Blondeau, B., & Guillemain, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020623 · Cited by 271
Cushing's disease: pathobiology, diagnosis, and management
Lonser, R. R., Nieman, L., & Oldfield, E. H. (2017) · Journal of Neurosurgery · doi:10.3171/2016.1.jns152119 · Cited by 215
Chornenkyy, Y., Wang, W., Wei, A., & Nelson, P. T. (2019) · Brain Pathology · doi:10.1111/bpa.12655 · Cited by 184
Neuropsychiatric disorders in Cushing's syndrome
Pivonello, R., Simeoli, C., De Martino, M. C., Cozzolino, A., De Leo, M., Iacuaniello, D., Pivonello, C., Negri, M., Pellecchia, M. T., Iasevoli, F., et al. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00129 · Cited by 174
Cushing’s disease: the burden of illness
Pivonello, R., De Martino, M. C., De Leo, M., Simeoli, C., & Colao, A. (2017) · Endocrine · doi:10.1007/s12020-016-0984-8 · Cited by 171
Herbert, J., & Lucassen, P. J. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2015.12.001 · Cited by 150
Psychiatric Symptoms in Patients with Cushing’s Syndrome: Prevalence, Diagnosis and Management
Vives, A. S., Resmini, E., Pascual, J. C., Crespo, I., & Webb, S. M. (2017) · Drugs · doi:10.1007/s40265-017-0735-z · Cited by 146
Neuropsychiatric Findings in Cushing Syndrome and Exogenous Glucocorticoid Administration
Starkman, M. N. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.05.010 · Cited by 102
Comorbidities in Cushing’s disease
Sharma, S. T., Nieman, L. K., & Feelders, R. A. (2015) · Pituitary · doi:10.1007/s11102-015-0645-6 · Cited by 101
Nieman, L. K., Castinetti, F., Newell-Price, J. D. C., Valassi, E., Drouin, J., Takahashi, Y., & Lacroix, A. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00588-w · Cited by 90
Glucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterations
Alcubierre, D. D., Ferrari, D., Mauro, G. C. D., Isidori, A. M., Tomlinson, J., & Pofi, R. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02091-7 · Cited by 79
Psychiatric and neurocognitive consequences of endogenous hypercortisolism
Piasecka, M., Papakokkinou, E., Valassi, E., Vives, A. S., Webb, S. M., de Vries, F., Pereira, A. M., & Ragnarsson, Ó. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13056 · Cited by 79
Quality of Life in Patients With Cushing's Disease
Vives, A. S., Resmini, E., Martínez-Momblán, M.-A., Valassi, E., Martel‐Duguech, L., & Webb, S. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00862 · Cited by 78
Tiemensma, J., Andela, C. D., Kaptein, A. A., Romijn, J. A., van der Mast, R. C., Biermasz, N. R., & Pereira, A. M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0023 · Cited by 73
Korbonits, M., Blair, J., Bogusławska, A., Ayuk, J., Davies, J. H., Druce, M. R., Evanson, J., Flanagan, D., Glynn, N., Higham, C., et al. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00949-7 · Cited by 71
Persistence of myopathy in Cushing’s syndrome: evaluation of the German Cushing’s Registry
Berr, C. M., Stieg, M. R., Deutschbein, T., Quinkler, M., Schmidmaier, R., Osswald, A., Reisch, N., Ritzel, K., Dimopoulou, C., Fazel, J., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0689 · Cited by 70
Persisting Muscle Dysfunction in Cushing’s Syndrome Despite Biochemical Remission
Vogel, F., Braun, L. T., Rubinstein, G., Zopp, S., Künzel, H., Strasding, F., Albani, A., Riester, A., Schmidmaier, R., Bidlingmaier, M., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa625 · Cited by 61
Pituitary adenomas and neuropsychological status: a systematic literature review
Pertichetti, M., Serioli, S., Belotti, F., Mattavelli, D., Schreiber, A., Cappelli, C., Padovani, A., Gasparotti, R., Nicolai, P., Fontanella, M. M., et al. (2019) · Neurosurgical Review · doi:10.1007/s10143-019-01134-z · Cited by 60
Valassi, E., Feelders, R., Maiter, D., Chanson, P., Yaneva, M., Reincke, M., Krsek, M., Tóth, M., Webb, S. M., Santos, A., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13600 · Cited by 59
Long-term effects of glucocorticoid excess on the brain
Dekkers, A. J., Amaya, J. M., van der Meulen, M., Biermasz, N. R., Meijer, O. C., & Pereira, A. M. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13142 · Cited by 56
“alerting, orienting or divided attention.(44) Sustained attention deficits were also reported in 20%–40% of patients with active CS, whereas simple attention functioning was preserved.”
BackgroundLong-term consequences of Cushing syndrome: a systematic literature review
Puglisi, S., Perini, A. M. E., Botto, C., Oliva, F., & Terzolo, M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad453 · Cited by 53
Long-term cognitive effects of glucocorticoid excess in Cushing’s syndrome
Forget, H., Lacroix, A., Bourdeau, I., & Cohen, H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.11.020 · Cited by 53
Ragnarsson, O., & Johannsson, G. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0534 · Cited by 51
Self-citationLolak, S., Suwannarat, P., & Lipsky, R. H. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800977-2.00005-x · Cited by 46
Altered neural processing of emotional faces in remitted Cushing's disease
Bas-Hoogendam, J. M., Andela, C. D., van der Werff, S. J. A., Pannekoek, J. N., van Steenbergen, H., Meijer, O. C., van Buchem, M. A., Rombouts, S. A. R. B., van der Mast, R. C., Biermasz, N. R., et al. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.05.001 · Cited by 44
Glad, C. A. M., Andersson-Assarsson, J. C., Berglund, P., Bergthorsdottir, R., Ragnarsson, O., & Johannsson, G. (2017) · Scientific Reports · doi:10.1038/srep44445 · Cited by 43
Self-citationMorbidity of Cushing’s Syndrome and Impact of Treatment
Webb, S. M., & Valassi, E. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.01.001 · Cited by 41
Fetal endocrine therapy for congenital adrenal hyperplasia should not be done
Miller, W. L. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.01.005 · Cited by 40
Stomby, A., Boraxbekk, C.-J., Lundquist, A., Nordin, A., Nilsson, L.-G., Adolfsson, R., Nyberg, L., & Olsson, T. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0352 · Cited by 40
Quality of Life in Cushing's disease: A long term issue?
Webb, S. M., Vives, A. S., Resmini, E., Martínez-Momblán, M.-A., Martel‐Duguech, L., & Valassi, E. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.03.007 · Cited by 38
Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome
Santos, A., Resmini, E., Gómez-Ansón, B., Crespo, I., Granell, E., Valassi, E., Pires, P., Vives-Gilabert, Y., Martínez-Momblán, M. A., de Juan, M., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0600 · Cited by 37
Ragnarsson, Ó., Glad, C. A. M., Bergthorsdottir, R., Almqvist, E. G., Ekerstad, E., Widell, H., Wängberg, B., & Johannsson, G. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0747 · Cited by 37
Self-citationResmini, E., Vives, A. S., & Webb, S. M. (2016) · Frontiers of hormone research · doi:10.1159/000443868 · Cited by 36
Major Depression as a Neuroprogressive Prelude to Dementia: What Is the Evidence?
Leonard, B. E. (2017) · Modern trends in psychiatry · doi:10.1159/000470807 · Cited by 35
Bengtsson, D., Ragnarsson, Ó., Berinder, K., Dahlqvist, P. M., Engström, B. E., Ekman, B., Höybye, C., Burman, P., & Wahlberg, J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab079 · Cited by 34
Ragnarsson, O., Glad, C. A. M., Berglund, P., Bergthorsdottir, R., Eder, D. N., & Johannsson, G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1906 · Cited by 33
Self-citationPatients' Perception On Clinical Outcome And Quality Of Life After A Diagnosis Of Cushing Syndrome
Papoian, V., Biller, B. M. K., Webb, S. M., Campbell, K. K., Hodin, R. A., & Phitayakorn, R. (2015) · Endocrine Practice · doi:10.4158/ep15855.or · Cited by 34
Ragnarsson, Ó., Stomby, A., Dahlqvist, P. M., Evang, J. A., Ryberg, M., Olsson, T., Bollerslev, J., Nyberg, L. H., & Johannsson, G. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.05.010 · Cited by 31
Self-citationMental Fatigue and Executive Dysfunction in Patients with Cushing’s Syndrome in Remission
Papakokkinou, E., Johansson, B., Berglund, P., & Ragnarsson, O. (2015) · Behavioural Neurology · doi:10.1155/2015/173653 · Cited by 29
Self-citationVogel, F., Braun, L., Zopp, S., Nowak, E., Schreiner, J., Benz, I., Rubinstein, G., Künzel, H., Ritzel, K., Kroiss, M., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad041 · Cited by 28
Alozie, E. (2015) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608059768115010014 · Cited by 26
Psychological complications of Cushing's syndrome
Vives, A. S., Webb, S. M., & Resmini, E. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000633 · Cited by 24
Cases of Psychiatric Morbidity in Pediatric Patients After Remission of Cushing Syndrome
Keil, M. F., Zametkin, A. J., Ryder, C., Lodish, M. B., & Stratakis, C. A. (2016) · PEDIATRICS · doi:10.1542/peds.2015-2234 · Cited by 24
The Roles of Exercise and Yoga in Ameliorating Depression as a Risk Factor for Cognitive Decline
Mathersul, D. C., & Rosenbaum, S. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/4612953 · Cited by 24
Biological Embedding of Psychosocial Stress Over the Life Course
Eachus, H., & Cunliffe, V. T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-811060-7.00012-7 · Cited by 22
Cushing Disease Presenting as Primary Psychiatric Illness: A Case Report and Literature Review
Rasmussen, S. A., Rosebush, P. I., Smyth, H. S., & Mazurek, M. F. (2015) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000113 · Cited by 22
Functional brain alterations in Cushing’s syndrome
Papakokkinou, E., & Ragnarsson, Ó. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1163482 · Cited by 20
Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess
Vogel, F., & Reincke, M. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09670-0 · Cited by 19
Stomby, A., Salami, A., Dahlqvist, P. M., Evang, J. A., Ryberg, M., Bollerslev, J., Olsson, T., Johannsson, G., & Ragnarsson, Ó. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0028 · Cited by 19
Self-citationGlucocorticoid Regulation of Food-Choice Behavior in Humans: Evidence from Cushing's Syndrome
Moeller, S. J., Couto, L., Cohen, V. V., Lalazar, Y., Makotkine, I., Williams, N., Yehuda, R., Goldstein, R. Z., & Geer, E. B. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00021 · Cited by 18
Cortical thickness abnormalities in long-term remitted Cushing’s disease
Bauduin, S., van der Pal, Z., Pereira, A. M., Meijer, O. C., Giltay, E. J., van der Wee, N. J. A., & van der Werff, S. J. A. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00980-6 · Cited by 18
Zhang, S.-Q., Cao, L., Liang, Y.-Y., & Wang, P. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.613421 · Cited by 18
The effect of retinal pigment epithelial cell patch size on growth factor expression
Vargis, E., Peterson, C. B., Morrell‐Falvey, J. L., Retterer, S. T., & Collier, C. P. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.016 · Cited by 17
Cao, C., Song, J., Yao, S., Yan, Y., Li, S., Peng, G., Ma, P., Du, H., Huang, C., Ding, H., et al. (2017) · Neuroreport · doi:10.1097/wnr.0000000000000757 · Cited by 15
Hormone levels are related to functional compensation in prolactinomas: A resting-state fMRI study
Yao, S., Cao, C., Lin, P., Juvekar, P., Zhang, R., Vera, M., Zeng, A., Golby, A. J., Xu, G., Tie, Y., et al. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116720 · Cited by 15
Neurologic Complications of Nondiabetic Endocrine Disorders
Ishii, M. (2014) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000450966.68828.45 · Cited by 14
Song, J., Cao, C., Yang, M., Yao, S., Yan, Y., Peng, G., Ma, P., Huang, C., Ding, H., & Xu, G. (2018) · Neuroreport · doi:10.1097/wnr.0000000000000965 · Cited by 13
Cao, C., Huang, Y., Chen, A., Xu, G., & Song, J. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.656255 · Cited by 12
Cognitive decline in Cushing's syndrome: A systematic review
Katragadda, A., Kunadia, J., Kirsch, P. M., Dorcely, B., Shah, S., Henig, Z., Job, A., Feelders, R. A., & Agrawal, N. (2024) · Journal of Neuroendocrinology · doi:10.1111/jne.13466 · Cited by 12
Tirosh, A., RaviPrakash, H., Papadakis, G. Z., Tatsi, C., Belyavskaya, E., Lyssikatos, C., Lodish, M. B., Bağcı, U., & Stratakis, C. A. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz303 · Cited by 12
The Future of Psychoneuroimmunology: Promises and Challenges
Halaris, A. E., Bechter, K., Haroon, E., Leonard, B. E., Miller, A. H., Pariante, C. M., & Zunszain, P. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-70554-5_15 · Cited by 11
Gao, L., Liu, L., Shi, L., Luo, Y., Wang, Z., Guo, X., & Xing, B. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09540-1 · Cited by 11
Neuropsychological functioning in patients with Cushing’s disease and Cushing’s syndrome
Siegel, S., Kirstein, C. F., Grzywotz, A., Hütter, B. O., Wrede, K. H., Kuhna, V., & Kreitschmann-Andermahr, I. (2021) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1247-4651 · Cited by 10
Lamos, E. M., & Munir, K. M. (2014) · Endocrine Practice · doi:10.4158/ep14068.ra · Cited by 10
Ohara, N., Suzuki, H., Suzuki, A., Kaneko, M., Ishizawa, M., Furukawa, K., Abe, T., Matsubayashi, Y., Yamada, T., Hanyu, O., et al. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s70611 · Cited by 10
Bauduin, S. E. E. C., den Rooijen, I. L. B., Meijer, M., van der Werff, S. J. A., Keo, A., Dzyubachyk, O., Pereira, A. M., Giltay, E. J., van der Wee, N. J. A., Meijer, O. C., et al. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105334 · Cited by 9
“These persistent impairments are predominant within the domains of cognitive function and psychopathology (Andela et al., 2013; Bas-Hoogendam et al., 2015; Dorn et al., 1995; Pereira et al., 2010; Pivonello et al., 2015; Ragnarsson et al., 2012; Sonino and Fava, 2001; Tiemensma et al., 2010).”
BackgroundRagnarsson, Ó., Berglund, P., Eder, D. N., Zetterberg, H., Hietala, M. A., Blennow, K., & Johannsson, G. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0205 · Cited by 9
Self-citationDo adrenal incidentalomas have an impact on mental health? A comprehensive review
Kaštelan, D., & Dušek, T. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf011 · Cited by 9
Walia, R., Kumar, N., Jarial, K. D. S., Bhansali, A. K., Nehra, R., & Vyas, S. (2020) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_162_20 · Cited by 9
Metformin and Bone Metabolism in Endogenous Glucocorticoid Excess: An Exploratory Study
Vogel, F., Braun, L., Rubinstein, G., Zopp, S., Oßwald, A., Schilbach, K., Schmidmaier, R., Bidlingmaier, M., & Reincke, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.765067 · Cited by 8
Sun, Y., Xu, J., Zheng, X., Li, C., Kong, D., Wu, Q., Zhu, Z., Feng, S., & Zhang, Y. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251338161 · Cited by 8
How to manage Cushing's disease after failed primary pituitary surgery
Agrawal, N., Urwyler, S. A., Mehta, S., Karavitaki, N., & Feelders, R. A. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae110 · Cited by 8
Structural and functional brain alterations in Cushing’s disease: A narrative review
Liu, Y.-F., Pan, L., & Feng, M. (2022) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2022.101033 · Cited by 8
The impact of pituitary adenomas on cognitive performance: a systematic review
Young, T.-C., Lin, K.-Y., Li, W.-C., Huang, C.-N., & Tsai, W.-H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1534635 · Cited by 7
Germann, S., Wimmer, R., Laager, R., Müeller, B., Schüetz, P., Kaegi-Braun, N., & Kutz, A. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae069 · Cited by 7
Shen, X., Jin, M., Wang, Y., Zhu, R., Wu, C., Ma, C., Zhao, X., & Su, F. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-09745-7 · Cited by 5
Feldkamp, L. L. I., Müller, L., Deutschbein, T., Detomas, M., Hahner, S., Strasburger, C. J., Kunzel, H. E., Oßwald, A., Braun, L., Rubinstein, G., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad043 · Cited by 5
Sabahi, M., Yousefi, O., Kehoe, L., Sasannia, S., Gerndt, C. H., Adada, B., Borghei-Razavi, H., Shahlaie, K., & Palmisciano, P. (2024) · World Neurosurgery · doi:10.1016/j.wneu.2024.04.154 · Cited by 5
Cao, C., Song, J., Lin, P., Yan, D., Yao, S., Yue, J., Liu, B., Yu-zhao, L., & Xu, G. (2020) · Clinical EEG and Neuroscience · doi:10.1177/1550059420922744 · Cited by 5
Cognitive Assessment in Adults With Adrenal Cortisol Insufficiency: Challenges and Opportunities
Ben-Shlomo, A., Koh, M., Kremen, S. A., & Wertheimer, J. C. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf029 · Cited by 4
Aerobic exercise interventions to address impaired quality of life in patients with pituitary tumors
Hong, C. S., & Smith, T. R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0295907 · Cited by 4
Brown, L. K. (2013) · CHEST Journal · doi:10.1378/chest.13-0508 · Cited by 4
McQueen, J., Garner, T., Chantzichristos, D., Lennernäs, H., Espiard, S., Ragnarsson, Ó., Bergthorsdottir, R., Skrtic, S., Stevens, A., & Johannsson, G. (2026) · Scientific Reports · doi:10.1038/s41598-026-37816-0 · Cited by 3
Self-citationLee, J., Li, C. H., Liu, C. J., Shiroishi, M. S., Carmichael, J. D., Zada, G., & Patel, V. N. (2022) · Surgical Neurology International · doi:10.25259/sni_787_2021 · Cited by 3
Socioeconomic status and its association with outcome in patients with Cushing's disease
Bengtsson, D., Järås, J., Burman, P., Wahlberg, J., & Ragnarsson, Ó. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf021 · Cited by 3
Long-Term Complications of Hypercortisolism
Pivonello, R., Iacuaniello, D., Simeoli, C., Martino, M. C. D., & Colao, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64305-2 · Cited by 2
From hypercortisolism to remission: impact of Cushing’s disease on eating patterns
Yilmaz, M. K., Burhan, H. Ş., Burhan, Ş., Niyazoğlu, M., & Hatipoğlu, E. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1726118 · Cited by 2
Hormonal Influences on Cognitive Function in Pituitary Neuroendocrine Tumors
Ku, J., Li, H., Bao, J., Dai, X., & Wang, B. (2025) · World Neurosurgery · doi:10.1016/j.wneu.2025.124548 · Cited by 1
Lirov, R., & Gauger, P. G. (2018) · Springer eBooks · doi:10.1007/978-981-10-1124-5_26 · Cited by 1
Glucocorticoids - outcome in patients with glucocorticoid deficiency and Cushing's syndrome
Ragnarsson, Ó. (2012) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Inoue, S., Hayashi, T., Teishima, J., & Matsubara, A. (2020) · Urologia Internationalis · doi:10.1159/000508765 · Cited by 1
Bengtsson, D. (2021) · Linköping University medical dissertations · doi:10.3384/diss.diva-174806 · Cited by 1
Stomby, A. (2015) · DiVA at Umeå University (Umeå University) · Cited by 1
Johansson, P. (2013) · Lund University Publications (Lund University) · doi:10.13140/rg.2.1.3188.4887 · Cited by 1
Ruggiero, B., Zhu, G., Swan, L., Suntornlohanakul, O., Xu, M., Ronchi, C. L., Elhassan, Y., Yates, D., & Prete, A. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag072 · Cited by 1
Schrenk, M., Haenelt, M., Oettle, M., Kroiss, M., Zopp, S., Braun, L., Rubinstein, G., Ritzel, K., Stüfchen, I., Stifel, U., et al. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag178 · Cited by 1
Liboz, A. (2022) · theses.fr (ABES) · doi:10.70675/9abd3277zd4c4z48f5za637z73aeb8a7a807 · Cited by 1
Metadata
- Authors
- Ragnarsson, O., Berglund, P., Eder, D. N., & Johannsson, G.
- Affiliations
- Institute of Medicine (O.R., G.J.), SE-413 45 Göteborg, Sweden
- University of Gothenburg (SE)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-09-01
- Volume
- 97
- Issue
- 9
- Pages
- E1640-E1648
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1987878757
- Cited by
- 111
- References
- 39
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 7 · 2023: 6 · 2022: 4 · 2021: 10 · 2020: 10 · 2019: 4 · 2018: 10 · 2017: 8 · 2016: 9 · 2015: 14 · 2014: 8 · 2013: 6 · 2012: 1
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Pfizer
- Viropharma
- Australian Government
- Novo Nordisk
- Sahlgrenska Universitetssjukhuset
- H. Lundbeck A/S
- Health and Medical Care Committee of the Regional Executive Board, Region Västra Götaland
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- Cushing's disease, Cushing's syndrome, remission, long-term remission, cognitive impairment, attention deficits, working memory, fatigue, depression, anxiety, executive function, spatial orienting, alerting
- MeSH terms
- Adrenal Cortex Neoplasms, Adrenalectomy, Adult, Aged, Arousal, Attention Deficit Disorder with Hyperactivity, Cognition Disorders, Corticotropin-Releasing Hormone, Cross-Sectional Studies, Dexamethasone, Fatigue, Female, Hormones, Humans, Hydrocortisone, Male, Middle Aged, Neuropsychological Tests, Social Class, Case-Control Studies, Age of Onset, Adrenocortical Adenoma, Pituitary ACTH Hypersecretion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.